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The  murine H-2 locus was  initially considered  a  single,  transplantation  antigen- 
encoding gene  (1).  However, by analysis of newly described traits  and recombinant 
mice, it is now clear that this locus is in fact a gene complex (2, 3). Genetic, functional, 
and  structural  interrelationships  exist  among  the  H-2  loci  (3).  Presently,  five H-2 
regions are recognized:  K,/, S, G, and D  (2,  3).  The I  region is the most intricate of 
these, having been divided into A, B,J, E, and C subregions (3).  The Ir-lA  (immune 
response)  locus demarcates the I-A subregion, which is bounded by the crossovers in 
recombinant haplotypes t 1 (A.TL) and y l  (AQR) on the left (centromeric) side, and 
by h4 [B10.A(4R)] and g2 (D2.GD) on the right side (3).  Several additional traits are 
controlled by I-A: immunosuppression, transplantation antigens, T  lymphocyte-stim- 
ulating  determinants,  cell-interaction  structures,  Ia  antigens,  and  determinants  on 
soluble helper factors and their respective receptors (3).  It is not clear whether these 
traits are manifestations of one or several structural  genes. Separation of I-A  loci by 
recombination is one approach whereby I-A complexity might be resolved. 
We suggest a  further subdivision of the I  region.  Specifically, I-A  is divisible into 
two subregions by intercalating a  new subregion,  I-N,  between K  and I-A. The I-N 
region is distinguished by a locus (or loci), Ia-7, which controls expression of a surface 
structure  on  a  lymphocyte subpopulation.  A  determinant,  which  provides a  strong 
proliferative stimulus  to  responding  cells in  mixed  leukocyte culture  (MLC),  maps 
within  I-N as  well.  The  left  boundary  of I-N is  established  by  the  cross-over  in 
recombinant AQR,  the right  boundary by the crossover in  recombinant A.TL. The 
designation I-N, rather than N, was chosen in view of the phenotypic traits under I-N 
control; these traits resemble more closely those that are I region controlled than those 
that are H-2K encoded. 
Materials and Methods 
Animals.  Mice (male and female, 6-12 wk old) were obtained from our colony. Guinea pigs 
were obtained from Mogul-Ed, Oshkosh, Wis. 
Media.  All  media and  supplements  were  purchased  from Grand  Island  Biological  Co., 
Grand  Island,  N.  Y.  Fetal  calf serum  (FCS)  was  obtained  from  Flow  Laboratories,  Inc., 
Rockville, Md. 
Antiserum.  (A.TL  ×  B10.D2)Fx  anti-Bl0.BR  serum  was  produced  by  intraperitoneally 
injecting each F1 recipient mouse with a suspension of B 10.BR spleen, lymph node, and thymus 
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cells (1  X  107 cells in  1 ml of phosphate-buffered saline)  weekly for 5 wk. Animals were bled 
from the retro-orbital sinus 4 d after the last immunization. In some experiments, diluted serum 
(75/11, 1:10 in medium 199 with 5% FCS) was absorbed twice with B10.T(6R) lymph node and 
spleen  cells (1 X  108 cells/absorption,  10 min at 4°C) before assay. 
Microcytotoxicity Test.  A  two-stage, dye-exclusion microcytotoxicity test  was performed on 
lymph node cell  targets according to Frelinger et al.  (4) with modifications suggested by Dr. 
Donal  Murphy  (Yale  University,  New  Haven,  Conn.  Personal  communication.)  (5). Fresh 
guinea pig serum, obtained bimonthly by heart puncture, served as complement. Complement 
controls were usually <5% dead cells. Between 100 and 200 cells were counted per well, 
MLC.  Mishell-Dutton medium supplemented with 2% FCS and 5 ×  10  -s M  2-mercapto- 
ethanol was used throughout (6). X-irradiated (2,000 R), washed splenocytes were pipeted into 
each of four replicate wells (0.5 ×  106 cells/well) ofa microtiter plate (Linbro 76-002-05, Linbro 
Chemical Co., Hamden, Conn.).  Responding lymph node cells were added to each well  (0.5 
×  10  n cells/well). Total culture vol was 0.2 ml. After 4 d at 37°C in a humidifed atmosphere of 
5% CO2 in air, an aliquot of [aH]thymidine (New England Nuclear, Boston, Mass., 25/~1 of 0.04 
mCi/ml  culture  medium)  was added  to each well.  Cultures  were  harvested  6  h  later,  and 
samples  were counted in  Aquasol  (New  England  Nuclear)  in  a  liquid  scintillation  counter 
(model 3330, Packard Instrument Co., Inc., Downers Grove, Ill.). 
Results 
Certain  primary,  MLC-proliferative  responses  (Fig.  1)  led  us  to  consider  the 
possibility  that  an  as yet undefined  locus  might  exist  between  K  and  I-A.  Table  I 
depicts the haplotypes of strains used in these and other experiments  (7).  Responding 
(A.TL  X  B10.D2)F]  cells were stimulated  with  cells  from three  strains;  stimulating 
strains were chosen such that genetic differences were limited  to discrete H-2 regions 
(Fig.  1, Exp.  I).  Fully H-2-incompatible C57BL/10 cells,  and I  region-incompatible 
B10.S(7R)  cells,  provoked strong proliferative  responses.  B10.BR  cells,  which  differ 
from the responding F1 hybrid at K, D, Qa, and Tla, resulted in a proliferative response 
equal to (two experiments)  or greater than  (three experiments)  the response either to 
C57BL/10 or to B10.S(7R).  Other K  and/or D  region-different  strain  combinations 
gave relatively weak proliferative responses, compared with H-2 or I  region-different 
strains  (Fig.  1, Exps. III and IV). 
Studies  with  a  second strain  combination  gave similar  results  (Fig.  1, Exp.  II). K 
region-disparate A.AL cells provided a proliferative stimulus to responding A.TL cells 
Exp.  Resp.  Slim.  Genelic  $H-Thymidine  uptoke  cpm x 10"3/well  -+  SD 
slroin  elroin  difference  20  40  60  80  I00 
I  (A.TL x  Fi  none 
BIO.D2)F  I  BIO.S(TR)  T,S,G 
BIO.BR  K,D 
BIO.M  K,I,S,G,D 
17  A.TL  A.TL  none 
A.TH  I,S,G 
A.AL  K 
A.AL+A.TH  K,[,S,G 
TIT  AQR  AQR  none 
BIO.T(6R)  T,S,G 
BIO.A  K 
BIO.RIIT  K,I,S,G,D 
I~  BIO.D2  BIO.D2  none 
BIO.HTG  D 
BIO  K,I,S,G,D 
i  t  i  i  i 
F[c.  1.  Primary proliferative responses of lymphocytes stimulated  by cells of strains that  differ 
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TABLE  I 
H-2 Haplotype of Strains Used in This Study (7) 
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H-2 region 
Strain  H-2 haplo-  I subregion 
type 
K  N  A  B  J  E  C  S  G  D 
Qa region 
1  2  3 
T/a 
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FIo.  2.  Reactivity  of  (A.TL  X  BI0.D2)F]  anti-Bl0.BR  serum  with  recombinant  strains.  (0) 
Unabsorbed serum; (O) B10.T(6R)-absorbed serum. 
equal to that observed with I region-different A.TL-stimulating  cells, or a  combination 
of !  region-different  A.TH  and  K  region-different  A.AL  cells.  The  results  in  Fig.  1 
(Exps.  I  and  II) could be reconciled with the abundance  of data  that suggest that the 
strongest  proliferative responses are elicited in I  region-different strain combinations 
(8-11), if an I  region-like locus were postulated  between  K  and 1-A.  This locus would 
demarcate  a  new  !  subregion,  1-N.  If A.TL  were  1-N  8,  it  would  then  be  1  region 
incompatible  with B10.BR  (1-N  k) and  A.AL  (1-Nk). 
Mice were immunized  with lymphocytes  from appropriate  strains in an attempt  to 
produce  antiserum  against  putative  I-N  products.  One  such  serum,  (A.TL  × 
B10.D2)F1  anti-B10.BR,  exhibits  a  reactivity  pattern  most  readily  explained  by 
postulating  an  1-N subregion.  Unabsorbed  serum  reacts  with  B10.BR,  B10.T(6R), 
and  AQR;  B10.T(6R)-absorbed  serum  retains  cytotoxicity  on  B10.BR  and  AQR 
lymphocytes  (Fig. 2  [mean lysis ___ SE of the mean  based on four separate experiments 
is shown]).  Specificities  encoded  by K k,  I-Nk(?),  /~,  Qa, and  Tla  may  potentially  be 
recognized  by  this antiserum  (Table  I).  B10.T(6R)  absorption  removes  antibody  to 484  HAYES AND BACIq  BRIEF  DEFINITIVE REPORT 
Qa, T/a, and cross-reactive H-2  q structures that might account for AQR lysis. Because 
reactivity to I-A  k, I-B  k, I-J  k, I-E  k, I-C  d, S  d, and G a determinants is ruled out  (because 
these  alleles  are  present  in  the  serum-producing  F1  hybrid  [no  autoantibody  was 
observed]), the antigen  detected  on AQR must  map between K  and  I-A.  It is very 
unlikely  that  the  anti-K  k and  anti-D  k antibodies  recognize cross-reactive, I  region- 
encoded  AQR  antigens.  These  results  provide  serologic  evidence  for  an  antigen, 
Ia.W41,  encoded  by  a  locus,  Ia-7,  within  a  new  I  subregion,  I-N  (provisionally 
designated). 
Discussion 
The strongest proliferative stimulus in a  primary MLC between ceils differing for 
the entire H-2 complex is encoded  by genes in  the I  region  (8-11).  In view of this 
finding,  the results  in  Fig.  1 (Exps.  I  and  II) appear anomolous;  these show strong 
proliferative responses between K- and/or D-incompatible strain pairs. B 10.BR (Exp. 
I) differs from the responding F1 at Qa and  Tla  in addition to K  and D, but Qa and 
Tla products do not stimulate in MLC  (12).  Recombinant A.TL (Exp. II) occurred 
among  the  progeny  of an  A.AL  to  A.SW  cross  (13);  it  differs  from  A.AL  at  a 
chromosomal segment to the left of the A.TL crossover, which includes H-2K. If the 
recombination in A.TL occurred such that an !  region-like locus were positioned to 
the left of the crossover, then A.TL would be I  region disparate from both B 10.BR 
and A.AL.  The MLC proliferative results  presented  would  then  be consistent  with 
earlier experiments (8-11). 
The  observation  that  (A.TL  ×  B10.D2)F1  recipients,  immunized  with  B10.BR, 
recognize an antigen on AQR that is not present on B10.T(6R), demonstrates a new 
k haplotype-encoded structure, Ia.W41, which is shared by B 10.BR but not by A.TL. 
AQR occurred among the progeny of a  (T138  X  B10.A)Fx to B10 backcross (14);  it 
derives genes that include D, Qa, and  Tla from B10.A.  B10.T(6R)  is derived from a 
cross between gray-lethal test stock and B10.A (15);  like AQR, it carried D, Qa, and 
Tla of B10.A. B10.T(6R) absorption, therefore, rules out the D, Qa, and Tla regions as 
sites for the  Ia.W41-encoding locus.  B10.T(6R)  and  AQR  also share  K q.  Although 
derived from different sources, these strains show complete cross-reactivity of major 
transplantation  antigens  (8).  Thus, Ia.W41  must be encoded by a  locus in the AQR 
genome  to  the  right  of K  and  to  the  left  of D.  The  serum  producer,  (A.TL  X 
B10.D2)F1,  carries alleles of both the  k  and  d  haplotypes from 1-A  through  G.  We 
conclude, therefore, that the Ia.W41-controlling gene maps between K  and l-A; that 
A.TL carries the s allele, whereas AQR carries the k allele; and finally, that Ia.W41 
and the crossovers in recombinants A.TL and AQR distinguish a new I subregion, I- 
N. 
We suggest  that  the new  locus  is properly related  to  the I  region.  Its product(s) 
appears to stimulate a  strong proliferative response in  MLC,  and it  is present on a 
subpopulation of lymphoid cells in contrast to the ubiquitous  I-I-2K products. Thus, 
the  1-N subregion,  which  lies at  the  boundary  between  two  distinct  regions  of the 
H-2 complex in terms of traits under their genetic control, appears to be a refinement 
of/-region genetic fine structure. The intercalation of I-N between H-2K and I-A will 
necessitate a  systematic reinterpretation  and  perhaps  reevaluation  of the  H-2 map 
position of many critically important immunological traits, which have been placed 
within the K or 1-A regions on the basis of recombinant analysis. HAYES  AND  BACH  BRIEF DEFINITIVE REPORT  485 
Summary 
Strong, primary mixed leukocyte culture-proliferative responses in certain K region- 
incompatible strain  combinations  led us  to consider whether  an  I  region-like locus 
might  exist between  K  and I-A.  Results obtained with an  (A.TL ×  B10.D2)F1  anti- 
B I0.BR  serum  provided  serological evidence  for a  new  locus;  B10.T(6R)-absorbed 
serum retained reactivity on AQR lymphocytes. This finding demonstrates an antigen, 
Ia.W41, encoded by a  locus, Ia-7, within a  new I subregion, I-N. 
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